Deepika Jalota

CIK: 0001825192

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (22.2%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (44.4%)

Compensation grants

Other (G, F, J, C, D, …)3 (33.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

PMVP

PMV Pharmaceuticals, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (9 total)

PMVP
PMV Pharmaceuticals, Inc.
Mar 5, 2026
Award(A)
Employee Stock Option (right to buy)
Direct
303.3K shares-
PMVP
PMV Pharmaceuticals, Inc.
Jul 1, 2025
Sale(S)
Direct
33.1K shares at avg. $1.06$35K
PMVP
PMV Pharmaceuticals, Inc.
Mar 3, 2025
Award(A)
Employee Stock Option (right to buy)
Direct
300K shares-
PMVP
PMV Pharmaceuticals, Inc.
Sep 11, 2024
Sale(S)
Direct
7.2K shares at avg. $1.50$11K
PMVP
PMV Pharmaceuticals, Inc.
Aug 13, 2024
Disposition(D)
Employee Stock Option (right to buy)
Direct
22.7K shares-
PMVP
PMV Pharmaceuticals, Inc.
Aug 13, 2024
Disposition(D)
Employee Stock Option (right to buy)
Direct
68.1K shares-
PMVP
PMV Pharmaceuticals, Inc.
Aug 13, 2024
Award(A)
Employee Stock Option (right to buy)
Direct
90.8K shares-
PMVP
PMV Pharmaceuticals, Inc.
Aug 13, 2024
Disposition(D)
Employee Stock Option (right to buy)
Direct
125K shares-
PMVP
PMV Pharmaceuticals, Inc.
Aug 13, 2024
Award(A)
Employee Stock Option (right to buy)
Direct
125K shares-

		Type	Shares	Price		Ownership
Mar 5, 2026	PMVP PMV Pharmaceuticals, Inc.	Award(A) Employee Stock Option (right to buy)	303,310	-	-	Direct
Jul 1, 2025	PMVP PMV Pharmaceuticals, Inc.	Sale(S)	33,065	$1.06	$35,198	Direct
Mar 3, 2025	PMVP PMV Pharmaceuticals, Inc.	Award(A) Employee Stock Option (right to buy)	300,000	-	-	Direct
Sep 11, 2024	PMVP PMV Pharmaceuticals, Inc.	Sale(S)	7,218	$1.50	$10,853	Direct
Aug 13, 2024	PMVP PMV Pharmaceuticals, Inc.	Disposition(D) Employee Stock Option (right to buy)	22,674	-	-	Direct
Aug 13, 2024	PMVP PMV Pharmaceuticals, Inc.	Disposition(D) Employee Stock Option (right to buy)	68,100	-	-	Direct
Aug 13, 2024	PMVP PMV Pharmaceuticals, Inc.	Award(A) Employee Stock Option (right to buy)	90,774	-	-	Direct
Aug 13, 2024	PMVP PMV Pharmaceuticals, Inc.	Disposition(D) Employee Stock Option (right to buy)	125,000	-	-	Direct
Aug 13, 2024	PMVP PMV Pharmaceuticals, Inc.	Award(A) Employee Stock Option (right to buy)	125,000	-	-	Direct

1-9 of 9 transactions

About Jalota Deepika

Jalota Deepika (SEC CIK 0001825192) files insider reports with the SEC as Chief Development Officer of PMV Pharmaceuticals, Inc. (PMVP).

Signal8 holds 5 ownership filings by Jalota Deepika, all Form 4s, filed between Sep 12, 2024 and Mar 9, 2026. Those filings report 9 transactions, from Aug 13, 2024 to Mar 5, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Jalota Deepika's filings is in PRINCETON, NJ.

Recent filings by Jalota Deepika

Mar 5, 2026: Grant or award of PMVP derivative securities (Form 4, code A).
Jul 1, 2025: Open-market sale of PMVP shares (Form 4, code S).
Mar 3, 2025: Grant or award of PMVP derivative securities (Form 4, code A).
Sep 11, 2024: Open-market sale of PMVP shares (Form 4, code S).
Aug 13, 2024: Disposition to issuer transactions of PMVP derivative securities (2 lines, Form 4, code D).

Other insiders filing for PMV Pharmaceuticals, Inc. (PMVP)

How to read Form 4 transaction codes